PTS33, a sodium derivative of CT, could selectively inhibit prostate cancer cells growth by inhibiting the expression of androgen receptor (AR) protein and blocking the expression of AR-regulated genes (Xu et al., 2012). Here, AR is linked to Familial prostate cancer.